In this sense, the first described molecular mechanism of constitutional activation of this pathway involved in oncogenesis was the loss of function of the tumour suppressor PTEN [122,123,124], although it is not clear whether this loss alone is sufficient for PI3K activation. This evidence concerns the gene PTEN and neoplasm.